semaglutide and eye disease NAION Network Study Announcement Semaglutide and other GLP-1 drugs
Description
Combining testosterone replacement therapy with GLP-1 receptor agonists is increasingly common among men pursuing dual metabolic and hormonal optimization
Thomas Kruse and Sren stergaard reflect on the development of the GLP-1 analogue, semaglutide, which is reshaping peptide therapeutics in type 2 diabetes, weight management, and beyond.
Personalized video message from Physician about your lab results with recommendations
A nationwide Swedish cohort found a higher relative risk ofanterior ischemic optic neuropathy among GLP-1 receptor agonist users, but theoverall risks were low.
Losing weight with GLP-1 medications
